ClaripulseClaripulse
MAUDE LookupResourcesBlog
LoginGet Early Access
ClaripulseClaripulse

Product

MAUDE LookupDashboard

Guides

FDA MAUDE DatabasePost-Market SurveillanceSignal Detection

Learn

BlogResourcesWhy Claripulse?

Legal

Privacy PolicyTerms of Service

This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified — do not attempt re-identification. © 2026 Claripulse.

Back to Coronary Intervention
MAUDE LookupCoronary InterventionPerclose ProGlide

Perclose ProGlide Adverse Events: FDA MAUDE Data

ABBOTT VASCULAR INC. · Vascular Hemostasis/Closure Device · First cleared Oct 2009

Total Reports

24,504

Reports (30d)

56

Active Signals

2

Open Recalls

0

Monthly Report Volume
Event Type Breakdown

What the reports describe · Claripulse analysis

Most commonly reported problems

1

Suture Break During Arteriotomy Closure

proglide device, arteriotomy closure, provided arteriotomy, proglide, sheath reportedly

68

reports

2

Literature Batch: TAVR Vascular Complications

valve, aortic, complications, proglide, prostyle

26

reports

3

Suture Release Failure During Closure

reported clinically, delay procedure, prostyle, prostyle device, femoral vein

17

reports

4

Device Link Abnormality During Pre-Close

pre close, arteriotomy closure, pre placed, close technique, prostyle

14

reports

5

Sutures Separated During Knot Advancement

pre close, using pre, pre placed, close technique, prostyle

11

reports

6

Foot Closure Failure with Device Removal

perclose, prostyle devices, sutures, prostyle, foot

7

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Detection

Active safety signals

Disproportionate reportinghighIncreasing trendcritical

Evidence

Related research

Angio-Seal Used as a Bailout for Incomplete Hemostasis After Dual Perclose ProGlide Deployment in Transcatheter Aortic Valve Implantation

Beytullah Çakal, et al. · Texas Heart Institute Journal · 2022

Watchman Device Procedure Complicated by Rare Perclose ProGlide Embolization: Case Report and Literature Review

Rafail Beshai · Cureus · 2022

Efficacy and safety of post-closure technique using Perclose ProGlide/ProStyle device for large-bore mechanical circulatory support access sites

Takashi Unoki, et al. · Cardiovascular revascularization medicine · 2023

Ambulatory pulmonary vein isolation workflow using the Perclose ProglideTM suture-mediated vascular closure device: the PRO-PVI study

Davide Fabbricatore, et al. · EP Europace · 2023

Femoral vessel cannulation strategies in minimally invasive cardiac surgery: single Perclose ProGlide versus open cut-down

Majd Ismail, et al. · European Journal of Cardio-Thoracic Surgery · 2025

Citations indexed from PubMed.

Keep exploring

Related devices in Coronary

Perclose ProStyle

ABBOTT VASCULAR INC. · 19,336 reports

→

PERCLOSE

ABBOTT VASCULAR INC. · 9,890 reports

→

Angio-Seal

TERUMO MEDICAL CORPORATION · 6,417 reports

→

SYNERGY

BOSTON SCIENTIFIC CORPORATION · 5,991 reports

→

Resolute Onyx

MEDTRONIC, INC. · 4,467 reports

→

Promus PREMIER

BOSTON SCIENTIFIC CORPORATION · 2,717 reports

→

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 2 active signals detected right now.

Get Early Access

Understanding this data

What FDA MAUDE data does and does not tell you

How these reports are filed, why raw counts mislead, and the limits to know before drawing conclusions.

→

How a safety signal is detected

What the "Active Signals" count above means and the methods that separate a real signal from noise.

→
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.